Wegovy lawsuits allege that manufacturer Novo Nordisk failed to warn consumers of all risks, negligently misrepresented the product and engaged in harmful marketing practices
Users commonly describe the experience as subtle but consistent, noticing gradual changes in appetite control, fewer cravings, and improved energy stability
Food preoccupation is often associated with dysregulated eating behaviors, ranging from loss-of-control eating (that is, eating with a subjective feeling of loss of control and associated distress) to binge eating (that is, the most extreme bout of loss-of-control eating)
It's primarily used for those with type 2 diabetes, but many people, including celebrities, have been using it - or similar weight loss jabs such as Wegovy - to drop the pounds
Beck and colleagues reported in 2014 that the 117-patient proof-of-concept study found ipamorelin well tolerated but did not reach statistical significance on its primary composite gastrointestinal endpoint at the studied dose